P
PRME
Prime Medicine
3.990
+0.410+11.45%After Hours: 4.000 +0.010 +0.25%19:59 10/09 EDT
OPEN/PREV CLOSE3.570/3.580
TODAY RANGE3.540-4.140
VOL8.07M
MARKET CAP723.69M
52 WEEK RANGE2.670-6.94
AVG VOL (3M)3.38M
% TURNOVER4.21%
TURNOVER--
P/E (TTM)-3.6606
% RANGE16.76%
EPS(TTM)-1.0900
P/E(FORWARD)-4.0382
P/B18.11
BVPS0.2203
DIVIDEND--
P/S155.25
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP576.72M
SHARES OUTSTANDING181.38M
NEXT EARNINGS11/05-11/09
FREE FLOAT144.54M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·16h ago
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
Benzinga·2d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·3d ago
Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
TipRanks·4d ago
Prime Medicine doses first patient in PM577a trial
TipRanks·10/01 14:26
Prime Medicine, Inc. (PRME) Gets a Buy from H.C. Wainwright
Seeking Alpha·09/29 11:30
Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
Seeking Alpha·09/25 20:00
Prime: A Buy Due To BLA Filing H1 '27 And Continued PM647 Advancement
Benzinga·09/25 17:56
Prime Medicine Gets FDA Green Light for Gene Editing Study
TipRanks·09/25 13:45
Oppenheimer Remains a Buy on Prime Medicine, Inc. (PRME)
Dow Jones·09/25 12:19
Prime Medicine Price Target Maintained With a $7.00/Share by Chardan Capital
Dow Jones·09/25 12:19
Prime Medicine Is Maintained at Buy by Chardan Capital
Seeking Alpha·09/25 10:45
At a glance: stocks gapping up premarket
Seeking Alpha·09/25 09:03
Prime Medicine stock jumps 8% after FDA clears PM647 trial